Literature DB >> 870837

Participation of prostaglandins in pathogenesis of aspirin-sensitive asthma.

A Szczeklik, R J Gryglewski, G Czerniawska-Mysik.   

Abstract

Recent evidence suggests that the induction of bronchoconstriction in aspirin-sensitive patients by analgesics is due to the inhibition of PG biosynthesis in their respiratory tract. PGEs might play the main defensive role in the bronchi of aspirin-sensitive asthmatics. Removal of this potent bronchodilator by PG synthetase inhibitors leaves the effects of spasmogens unopposed, and possibly promotes the release of histamine from its stores.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 870837     DOI: 10.1007/bf00587792

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  2 in total

1.  Relationship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirin-sensitive patients.

Authors:  A Szczeklik; R J Gryglewski; G Czerniawska-Mysik
Journal:  Br Med J       Date:  1975-01-11

2.  Aspirin-induced asthma. Hypersensitivity to fenoprofen and ibuprofen in relation to their inhibitory action on prostaglandin generation by different microsomal enzymic preparations.

Authors:  A Szczeklik; R J Gryglewski; G Czerniawska-Mysik; A Zmuda
Journal:  J Allergy Clin Immunol       Date:  1976-07       Impact factor: 10.793

  2 in total
  3 in total

Review 1.  Aspirin-Exacerbated Diseases: Advances in Asthma with Nasal Polyposis, Urticaria, Angioedema, and Anaphylaxis.

Authors:  Whitney Stevens; Kathleen Buchheit; Katherine N Cahill
Journal:  Curr Allergy Asthma Rep       Date:  2015-12       Impact factor: 4.806

Review 2.  Aspirin, paracetamol and non-steroidal anti-inflammatory drugs. A comparative review of side effects.

Authors:  P D Fowler
Journal:  Med Toxicol Adverse Drug Exp       Date:  1987 Sep-Oct

3.  [Pain syndromes affecting the locomotor apparatus. Clinical signs, differential diagnosis and therapy.].

Authors:  K Arndt; A Struppler
Journal:  Schmerz       Date:  1988-03       Impact factor: 1.107

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.